Latest filing published 14 May 2024 for Vaccinex, INC., €2,895.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Gerald E. Van Strydonck: trading record in brief
Gerald E. Van Strydonck (board member) discloses dealings in Vaccinex, Inc. to SEC (Form 4). Between 23 February 2022 and 10 May 2024, the trades on record add up to 6 filings.
Both buying and selling appear: 2 purchases worth €23k, against 2 sales worth €2,886. On balance, insiders were net buyers of €20k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants.
The newest entry dates from 14 May 2024: a share grant of €2,895, in Vaccinex, Inc. The latest purchase dates back some time: it was published 1,718 days ago, on 24 February 2022. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gerald E. Van Strydonck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 543 shares@ US$5.759.0% of flowCommon StockSEC:0001062993-24-010183:0
- 3,149 shares@ US$0.726.4% of flowCommon StockSEC:0001062993-23-023239:0
- 1,334 shares@ US$0.672.6% of flowCommon StockSEC:0001062993-23-022436:0
- 47,232 shares@ US$0.529375.0% of flowCommon StockSEC:0001062993-22-022813:0
- 2,000 shares@ US$1.307.1% of flowCommon StockSEC:0001062993-22-005567:0Canonical exit: 24 May 2022 (T+90)
5 of 5 declarations